In Brief Chung et al. define the protein network in the vicinity of a-synuclein in living neurons using a peroxidase labeling technique coupled with mass spectrometry. a-synuclein directly interacts with proteins involved in synaptic transmission, endocytosis, retromer trafficking and mRNA translation.
INTRODUCTION
Neurodegenerative diseases are characterized by the loss of distinct neuronal populations. In most of these diseases, a critical event leading to this neuronal loss is the abnormal folding and mis-trafficking of proteins. Different diseases are defined by the particular culprit proteins and the specific cell-types affected. For example, abnormal intraneuronal accumulation of the protein a-synuclein (a-syn) defines the synucleinopathies, a group of diseases that includes Parkinson's disease (PD) and dementia with Lewy bodies (DLB) (Goedert et al., 2013) . In these diseases, midbrain dopaminergic and cortical glutamatergic neurons are among the neuronal populations that prominently degenerate; their degeneration is associated with clinically important phenotypes. a-syn is encoded by the SNCA gene. The identification in PD of mutations and polymorphisms at the SNCA gene locus has causally tied the misfolding of this protein to disease (Shulman et al., 2010) .
asyn is a highly abundant neuronal protein. Early studies localized a-syn predominantly to the pre-synaptic terminal (Maroteaux et al., 1988) . Subsequent studies have concentrated on this synaptic localization, and its apposition to synaptic vesicles (Auluck et al., 2010) . Abundant evidence now indicates that a-syn is found on the cytosolic face of vesicles and adopts an amphipathic conformation upon binding phospholipid membranes (Auluck et al., 2010; Davidson et al., 1998; Mizuno et al., 2012) . Its localization to other cellular compartments, including the nucleus, remains relatively under-explored but may be relevant to disease (Kontopoulos et al., 2006) . Beyond neurons, a-syn is also abundant in other cell types, notably red blood cells (Nakai et al., 2007) . While its biological function remains far from fully known, findings in cellular models from yeast to neurons have coalesced around important roles for a-syn in vesicle trafficking and synaptic physiology (Greten-Harrison et al., 2010; Chandra et al., 2005; Auluck et al., 2010; Vargas et al., 2014; Scott et al., 2010; Gitler et al., 2008) . These studies have suggested that the normal physiological function of the protein is related to its cellular pathology. Thus, knowledge of a-syn localization and native interactions may also shed light on disease mechanisms when the protein misfolds and mis-traffics.
The elucidation of a protein's physical interactions can provide essential clues to its function. For a-syn, a number of complementary approaches have been used to identify around 300 physical interactions (http://thebiogrid.org/112506/summary/ homo-sapiens/snca.html). First, co-immunoprecipitation has been used in conjunction with mass spectrometry to delineate diverse protein-protein associations (McFarland et al., 2008) . While this methodology is unbiased and high-throughput, it depends on lysis of cells that disrupts the native cellular context. Moreover, only stable, protein complexes are recovered by standard co-immunoprecipitation techniques. Second, low-throughput candidate-based experiments have validated biochemical interactions between a-syn and numerous other proteins and demonstrated that specific interactions with a-syn are required for specific physiological functions. These include the identification of interactions between the C terminus of a-syn and SNARE proteins such as Synaptobrevin-2/VAMP2 and SNAP-25 (Sharma et al., 2012) . Complemetary a-syn knockout experiments suggest a role for a-syn in SNARE complex assembly during exocytosis (Burré et al., 2014; Burré et al., 2010) and subsequent studies have extended this function to multiple steps in vesicle trafficking, including endocytosis (Vargas et al., 2014) . Additional low-throughput interaction studies, including reconstitution in multi-protein complexes, have revealed biochemical interactions between a-syn and other proteins implicated in PD, including the microtubule-associated protein Tau (encoded by the MAPT gene) (Jensen et al., 1999) and Parkin (Choi et al., 2001) . Finally, it is worth noting that conventional yeast-two-hybrid technologies-in which a prey and bait protein must interact in the nucleus of yeast cells for a positive readout of the assay-have been largely unsuccessful in recovering any interactions for a-syn (Engelender et al., 1999) , likely because meaningful interactions for a membrane-associated protein like a-syn may critically depend on subcellular context.
In this study, we built on previous work and defined the aÀsyn's physiologic compartments within the cell and its protein-protein interaction network within its native environment using a chemical biology approach. In the presence of H 2 0 2 , ascorbate peroxidase (APEX) oxidizes numerous phenol derivatives to phenoxyl radicals. Such radicals are short-lived (<1 msec) and can covalently react with electron-rich amino acids such as Tyr within their small labeling radius (<10 nm). This chemistry combined with mass spectrometry was recently exploited to define the proteome of organelles, including the mitochondrial matrix (Rhee et al., 2013) and intermembrane space (Hung et al., 2014) . The overarching advantage of this technique is that the labeling is performed when the cell is still alive, with all membranes and protein-protein interactions preserved, including transient interactions.
Rather than using the APEX tag-based methodology to define the proteome of an organelle or cellular compartment, we used it here to define the proteins in the immediate vicinity of a-syn in mammalian cells, including primary neurons. We then used two orthogonal assays (co-immunoprecipitation and membrane-2-hybrid [MYTH]; Stagljar et al., 1998) to ask whether proteins identified through APEX interacted with a-syn in physical complexes. In order to address the significance of these proteins and their functional compartments to a-syn proteotoxicity, we compared them to a comprehensive genetic network generated through unbiased genome-wide screens against a-syn toxicity (accompanying manuscript Khurana et al., 
this issue of Cell Systems).
In sum, the use of multiple orthogonal approaches in this study defines the intrinsic localization and protein interaction network of a-syn, and their intimate relationship to its proteotoxicity.
RESULTS

APEX Defines the In Situ Proteome of a-syn in Neurons
We first tested the APEX-based approach for defining a-syn's protein neighborood in HEK293 cells. The data from HEK293 cells confirmed that APEX could yield useful information on the localization, neighboring proteome and protein-protein interactions of a-syn in living cells (see Figures S1 and S2 and Table  S1 for complete details).
The misfolding of a-syn causes pathology in neurons, including loss of dopaminergic and cortical neurons. We thus optimized the APEX technique in this more disease-relevant cell type. We utilized primary rat cortical neurons that can be cultured in high abundance at relatively high levels of consistency and homogeneity compared to dopaminergic neurons. We used a ''second-generation'' APEX with improved catalytic efficiency (APEX2) (Lam et al., 2015) . This has been optimized for robust labeling in live neurons when expressed under the synapsin promoter. We tagged APEX2 to the C-terminal, cytosol facing end of aÀsyn, allowing the enzyme to be directed to the native cellular environment of aÀsyn ( Figure 1A) .
After 10 days in culture, we transduced a-syn-APEX2 into rat primary cortical neurons using lentivirus. At this time point, endogenous a-syn is fully expressed. We have previously shown that at a multiplicity of infection (MOI) of 20, a-syn overexpression from an extremely strong CMV promoter causes overt toxicity only after 2 weeks (Chung et al., 2013) . To avoid the potentially confounding effects of neurotoxicity on our proteomic analysis, we transduced neurons at an MOI of 5 and expressing a-syn from a synapsin promoter, well below toxic levels. Three days after viral transduction, we activated APEX by a short (1 min) pulse of H 2 0 2 in the presence of biotin-phenol immediately prior to lysing the cells ( Figure 1B) .
APEX2 produced robust and specific labeling patterns in neurons. For aSyn-APEX2, this localization was punctate in neurites as expected. In contrast, nucleus-excluded APEX2 (NES-APEX2) showed diffuse cytosolic and neuritic labeling. Mito-APEX2 labeling was consistent with discrete mitochondrial localization ( Figure 1C ). Biotinylated proteins from aSyn-APEX2, NES-APEX2 and APEX2-negative neurons ( Figure 1D ) were quantified using isobaric tags for relative and absolute quantification (iTRAQ) mass spectrometry ( Figure S3 ). More than 2,000 proteins were identified by MS, and after filtering the dataset for nonspecific cytosolic labeling by comparing enrichment in the a-syn-APEX2 condition versus the NES-APEX2 control (see Figure S4 and STAR Methods for full details) we identified 225 enriched proteins proximal to a-syn in cortical neurons (Table S2) .
Of the 225, there was enrichment for proteins in subcellular compartments previously associated with a-syn, including vesicles and the synaptic terminal ( Figure 1E , Figure S5 and Table  S3 ). Cellular processes such as protein transport and vesicle trafficking (including clathrin-mediated endocytosis and retromer-mediated retrograde trafficking) were among the top pathways enriched (Table 1) .
Beyond the expected localization at the synaptic terminal and vesicle compartments, the a-syn-APEX2 analysis also implicated other compartments, pathways and processes including actin and microtubule cytoskeleton and serine/threonine-specific dephosphorylation (Table 1 ). The cytoskeletal proteins included the microtubule-associated protein tau (MAPT) that has been heavily implicated in distinct forms of parkinsonism. MAPT polymorphisms are independent risk factors for PD (Shulman et al., 2010) , and physical interactions between MAPT and a-syn have been well described in the literature (Jensen et al., 1999) . Particularly prominent classes of proteins significantly enriched among the a-syn-APEX2-labeled proteins were mRNA binding, processing, and translation proteins. These were explored in more detail below.
MYTH and Genetic Interaction Analysis Confirm a Direct
Effect of a-syn on Endocytic and Retrograde Trafficking Pathways a-syn-APEX2 prominently labeled clathrin-mediated endocytic proteins, as well as two proteins within the retromer complex that traffics proteins from endosomes to late Golgi, VPS29 and VPS35. These are pathways and proteins that have been strongly implicated in human studies of PD. Indeed, the VPS35 gene is also known as the PARK17 locus because mutation of its coding sequences causes Mendelian PD (Zimprich et al., 2011; Hunn et al., 2015) . The APEX2 data alone cannot distinguish whether a-syn was simply located in the endocytic and retrograde trafficking compartments, or if it was bound in macromolecular complexes to these proteins. So, for each protein in the endocytic or retrograde trafficking pathway that emerged in our APEX dataset, we performed a binary a-syn interaction assay with membrane yeast two-hybrid (MYTH, see STAR Methods, Figure S2 and Table S5 ). We tested all isoforms available in the ORFeome for 19 endocytosis/retromer proteins suggested by APEX. Of these, 10/19 were positive with MYTH. These included Clathrin, Dynamin, and VPS29 ( Figure 2A , Table S5 ). Another retromerassociated protein, SNX1, also formed a complex with aÀsyn ( Figure 2A ) but the closely related retromer proteins, VPS35 and SNX5, did not. Our data suggests that a-syn impacts endocytic and retrograde trafficking through direct physical interactions with key proteins in these pathways.
While a-syn-APEX2 in conjunction with MYTH can uncover physical interactions between proteins, as noted above, complementary genetic approaches are required to reveal the biological significance of these interactions. In an accompanying manuscript (Khurana et al., 2017 , this issue), we executed three genome-wide screens in yeast to identify genes that impact a-syn toxicity. Homologs of a number of human PD genes, including VPS35, were recovered in these screens. Loss of VPS35 enhances a-syn toxicity, confirmed here for a strain that expresses moderately toxic levels of a-syn (IntTox) (Figure 2B ). The convergence of both physical and genetic interaction data on the same protein complexes substantiates these direct interactions between a-syn and its neighboring proteins as inciting events in a-syn toxicity.
Our genetic screens did not recover the two other core retromer components, VPS26 or VPS29, as modifiers of a-syn toxicity. However, high-throughput screens are never comprehensive. In this case, the identification of VPS29 in our spatial assays (a-syn-APEX2 and MYTH) led us to test the effects of deleting each of the retromer genes on a-syn toxicity in a candidate-based experiment. In fact, deletion of VPS26 or VPS29 also enhanced a-syn toxicity ( Figure 2B ). Thus, these independent genetic and physical interaction analyses were mutually reinforcing and complementary. In this case, the retromer emerges as a multi-protein complex that interacts physically with a-syn and plays a key role in its toxicity. These connections to a-syn and its toxicity provide important biological context for VPS35 (PARK17) as a PD gene. Figure S6 shows an adaptation of the entire endocytosis pathway from the Kegg database demonstrating the substantial data linking this pathway to a-syn in both our genetic (red star) and spatial (green for APEX2; yellow for MYTH) analyses.
Convergence of Genetic and Spatial Maps on Vesicle
Trafficking and mRNA Translation Taking our lead from the retromer-a-syn interaction, we looked more broadly at the relationship of genetic modifiers of a-syn toxicity to the spatial a-syn-APEX2 map. In the accompanying manuscript, we developed computational methods that could assemble genetic modifiers of a-syn toxicity into molecular Protein trafficking, transport and endocytosis were the top category labeled by a-syn-APEX2. In addition, cytoskeleton (actin and microtubule), protein phosphatases and mRNA metabolism (RNA binding and protein synthesis) are the processes that are labeled by a-syn-APEX2. Gene ontology enrichment scores for biological process; DAVID functional annotation clustering https://david.ncifcrf.gov.
networks and place these networks squarely in the context of the human proteome. This network is represented in Figure 3A .
Many core components of the genetic network encode proteins that our a-syn-APEX2 and MYTH analysis revealed were in the immediate vicinity of a-syn ( Figure 3A , filled circles).
Beyond the retromer complex, these include proteins involved in other trafficking steps (RAB6A, Synaptojanin/SYNJ1), mRNA translation factors and other mRNA binding proteins (PABPC1, G3BP1/2,TIA1/TIAL1), signaling proteins and phosphatases (Calcineurin/PPP3C, PPP1C). The overlap between genetic and spatial maps extends beyond these specific proteins. For example, while the spatial map identified a-syn in the immediate vicinity of Rps10, the ge-A B Figure 2 . Endocytic and Retromer Trafficking Proteins Interact with a-syn Physically and Genetically (A) Endocytic and retromer trafficking proteins enriched in a-syn-APEX2-labeled neurons are tested for physical interaction with a-syn using the membrane-2-hybrid (MYTH) technique ( Figure S2 ). Figure 3A and Table S4 ). Of the mRNA translation hits in the APEX neuron study, 5 were available for testing by MYTH in the ORFeome library. Of these, 4/5 were confirmed (EIF3C, EIF3L, RPS12 and PABPC1; Figure 3B; Table S5 and Figure S7 ). These data imply that, as for vesicle trafficking proteins, mRNA translation and binding proteins are proximal interactors with a-syn that are integrally involved in its mechanisms of toxicity. This was also supported by the results from our accompanying paper, where we identified a defect in mRNA translation in PD patient-dervied neurons (Khurana et al., in this issue) . It is worth noting that, while the genetic map of a-syn toxicity was generated in yeast, the spatial a-syn-APEX map was established in mammalian neurons. While the yeast genetic map was ''humanized'' (that is, placed in the context of the human proteome), a number of important relationships would likely be missed, most likely for proteins that are neuron-specific. This indeed was the case. For example, the spatial aÀsyn map recovered multiple RAB3 proteins. These are neuron-specific RAB proteins involved in synaptic vesicle exocytosis and do not feature among our genetic screen hits in yeast. However, multiple previous studies, including from our own lab, have established that modulating the levels of these RAB proteins can modify a-syn toxicity in neurons, shown for both RAB3A (Gitler et al., 2008) and RAB3B (Chung et al., 2009 ).
Finally, another measure of the biological significance of our spatial a-syn map comes from human genetic studies. Our genetic and spatial maps converged on specific human neurodegenerative disease genes ( Figure 3C ), including two Mendelian parkinsonism genes, VPS35 (PARK17) (Zimprich et al., 2011) and SYNJ1 (PARK20) (Quadri et al., 2013; Olgiati et al., 2014; Krebs et al., 2013) . Also recovered in the spatial map was PARKIN (PARK2). While PARKIN does not have a direct yeast homolog, a related ubiquitin ligase in yeast, Cdc4 (FBXW7) (Ivatt et al., 2014; Ekholm-Reed et al., 2013) , was recovered in our genetic screens. A third PARK gene, DNAJC6 (PARK19) (Kö ro glu et al., 2013; Olgiati et al., 2015; Edvardson et al., 2012) , was recovered in the spatial map. DNAJC6 is also known as an auxilin, and is a chaperone involved in clathrin uncoating. One PARK gene that is no longer considered a bona fide PD gene because of failure to replicate in human genetic studies is UCHL1 (PARK5). It appeared in both our genetic and spatial maps, suggesting that it may be involved in a-syn toxicity. In fact, a number of mechanistic studies have previously suggested such a relationship (Cartier et al., 2012; Liu et al., 2009; Yasuda et al., 2009 ) and this association may be of relevance in the broader context of synuclein pathology beyond PD. Beyond Mendelian risk factors, our spatial map further recovered two neuronal genes implicated through common variants in PD, MAPT and Syntaxin 1B (STX1B) (Nalls et al., 2014) . Finally, like VCP, two other proteins related to multisystem proteinopathies, were recovered in our spatial map, (A) a-syn-APEX2-labeled proteins are overlaid on to a ''humanized'' genetic interaction network map. Each circular node of the genetic network depicts a human protein related to a genetic modifier of a-syn toxicity in yeast (full details in Khurana et al., 2017 , this issue), or an a-syn-APEX2-labeled protein that is in a complex with a genetic hit. Enlargement of certain nodes is purely for emphasis and readability. Nodes that belong to both the genetic and a-syn-APEX2 maps are indicated fully shaded. These include G3BP1/2, TIA/TIAL1, PABPC1, VPS29, vPS35, RAB6A, PPP1CB, PPP3C (Calcineurin), TLN1 (Talin 1) and PRMT (Protein Arginine Methyl Transferase). Nodes that were only recovered as genetic modifiers are marked with a left semi-circle. Conversely, nodes that were only recovered in the spatial a-syn-APEX2 map are indicated with a right semi-circle. Pathways/processes that are enriched in both genetic and spatial maps include vesicle trafficking, mRNA metabolism and mRNA binding proteins and phosphatases (Gene ontology enrichment scores for cellular compartment; DAVID functional annotation clustering https://david.ncifcrf.gov).
(B) mRNA translation-related proteins are tested for physical interaction with a-syn using the membrane-2-hybrid (MYTH) technique. Interactions scored as positive are marked ''+.'' Positive and negative controls are shown in the box. (C) Neurodegenerative disease-associated genes emerge among a-syn-APEX2-labeled proteins. Some of these are also recovered in the genetic network of a-syn toxicity modifiers (Khurana et al., 2017 ; full circles). Others are not (left semi-circle). VCP was among the a-syn-APEX2-labeled proteins. While VCP was not directly recovered as a genetic modifier of a-syn toxicity, two proteins that work closely with VCP in endoplasmic reticulum-and mitochondria-associated degradation -SYVN1 and ANKZF1 -were recovered in genetic screens. Notably, a gene no longer considered a PD gene (UCHL1/PARK5) was recovered in both the spatial and genetic a-syn maps.
including HNRNPA1 and HNRNPA2B (M€ uller-Kuller et al., 2015; Taylor 2015; Kim et al., 2013) . These findings collectively deepen our understanding of a-syn toxicity, and specifically establish a key relationship between the native cellular context of the a-syn protein in neurons to pathogenic mechanisms of high relevance to human disease.
DISCUSSION
How the intrinsic localization of a misfolding protein relates to its proteotoxicity has been unclear. The major advance of the APEX2 labeling methodology is its ability to capture the localization of a protein and its proteome context within a living cell. It provides a snapshot of proteins, somewhat analogous to immunocytochemistry, except that APEX2 provides information at proteome-scale that is independent of the idiosyncrasies of immunohistochemistry. In short, APEX2 captures subcellular complexity and spatial context. This is not captured by techniques that require cell lysis, like co-IP, or with heterologous systems such as MYTH, in which a bait protein is tethered to the ER membrane. However, APEX2 will also label proteins that are in the vicinity of the tagged protein, but not necessarily complexed to it directly. It is also important to point out that the APEX2 tag could impede protein-protein interactions or the entry of the tagged protein to specific subcellular compartments. Moreover, proteins without surface-accessible Tyr or other electron-rich residues will not be detected with the APEX technique. These different methodologies are thus complementary. When they are convergent, they are mutually reinforcing. When they are divergent, interactions are worthy of investigation with yet additional methods. At a high level, this study and the accompanying work (Khurana et al., 2017) systematically explore a-syn toxicity through a variety of complementary, independent methodologies: physical and spatial mapping techniques like APEX2 and MYTH, multiple genetic screens, computational tools, and functional validation in patient-derived neurons. Proteins that emerge in common between these approaches, proximal as they are to a-syn itself, are likely to reflect direct and inciting events in a-syn cytotoxicity. These include vesicle trafficking proteins (RAB6A, VPS35, SYNJ1), mRNA translation factors (PABPC1) and key signaling molecules (PPP3/Calcineurin). The correlation with entirely independent human genetic studies reinforces the significance of these proteins and pathways to human disease. Most broadly, the building of molecular networks with our various approaches provides a view of how seemingly disparate genes, proteins and pathways interconnect to cause proteotoxicity.
While these methods are powerful, they clearly do not replace deeper, mechanistic studies or studies in more complex models. For example, in the accompanying study the emergence of mRNA translation factors in our spatial and genetic networks allowed us to uncover new pathologic phenotypes in patientderived neurons. Hence, the main strength of these studies is to identify important directions for future investigations. While mechanistic work within a neuronal context is required for a more detailed understanding of clinical observations, our studies provide a systems-level view of how intrinsic biology might relate to the pathology of misfolded and mis-trafficked proteins. These approaches can now be applied to other proteinopathies in which a relationship of intrinsic biology to disease pathology may well emerge as a common theme.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Yeast strains for membrane 2 hybird: The genotype of the host yeast strain NMY51 (Dualsystems Biotech AG, Schlieren, Switzerland) is MATa his3delta200 8-ADE2 GAL4. Yeast strains for overexpression genetics: The yeast strains used were in the w303 background (MATa can1-100, his3-11,15, leu2-3,112, trp1-1, ura3-1, ade2-1). The NoTox a-syn strain contained a-syn fused to green fluorescent protein (a-syn-GFP) inserted at the his locus (pAG303Gal-a-syn-GFP). IntTox strain contained multiple tandem copies of a-syn-GFP inserted at the his and trp loci (pRS303GAL-a-syn-GFP, pRS304GAL-a-syn-GFP). IntTox strains have 4-5 copies of a-syn.
METHOD DETAILS
In Situ Biotin Labeling of aSyn Interactors Using aSyn-APEX The labeling protocol was modified from the recent publication by Rhee et al. Genetically engineered APEX was tagged to the C-terminal of aSyn under the CMV promoter. For HEK293T cells grown in DMEM with 10% fetal bovine serum, the plasmid carrying aSyn-APEX was transiently transfected using lipofectamine 2000 (Life Technologies). 24-48 hr after transfection for HEK293T, cells were incubated in 500 mM biotin tyramide dissolved in Optimem for 30 min at 37 C. H 2 O 2 was added at a final concentration of 1 mM for exactly 1 min at room temperature by washing the cells twice with PBS containing quenching reagents (5 mM Trolox, 10 mM ascorbic acid and 10 mM NaN3) for 30 s and another two washes with PBS. For a control sample for the pull down, aSyn-APEX was omitted. As for the rat primary neurons, lentivirus with synapsin promoter carrying aSyn-APEX2, NES-APEX2, mito-APEX2 was transduced at a multiplicity of infection 5. 3 days post-transduction, neurons were labeled the same way as described above. For washing, the same solution except NaN3 was used. After the final wash, cells were either fixed with 4% paraformaldehyde for immunofluorescent staining or lysed with RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton x-100, 0.5% Sodium deoxycholate, 0.1% SDS and 1 mM EDTA) with protease inhibitor cocktail (Sigma) on ice for 20 min. Lysates were centrifuged for 20 min at 10,000 xg at 4 C. Supernatant was collected and protein concentration was measured using the BCA assay. Biotinylation in the samples were detected by western blot followed by probing with horseradish peroxidase-conjugated avidin (Vector Laboratories). For immunocytochemistry, Streptavidin conjugated AlexaFluor 568 (Thermo Fisher Scientific) was used. For mass spectrometry experiments, 1$2 mg of protein was incubated with 200 mL of streptavidin magnetic bead (Pierce) slurry for 1 hr at room temperature. Beads were washed by rocking for 5 min in RIPA buffer containing 400 mM NaCl for two times, once with 1M KCl, once with 0.1 Na carbonate (pH 11.5), REAGENT 15, 112, ade2 twice with 2M Urea, and twice with RIPA. After the final wash, beads were boiled for 5 min in 60 mL of 1X LDS buffer (Life Technologies) + 1X reducing agent (Life Technologies) for HEK cells. The denatured solution was loaded into gel for mass spectrometry analysis. As for the primary rat cortical neurons, beads right after washing were given for further processing at Broad Institute for mass spectrometry.
Rat Primary Cortical Cultures
Embryos were harvested by cesarean section from anesthetized pregnant Sprague-Dawley rats at embryonic day 18. Cerebral cortices were isolated and dissociated with Accumax digestion for 20 min at 37 C and triuration with Pasteur pipette. Poly-ornithine and lamin-coated 96 well plates or 8 well-chambered coverglass were seeded with 4x10 4 or 8x10 4 cells respectively in neurobasal medium (Life Technologies) supplemented with B27 (Life Technologies), 0.5 mM glutamine, 25 mM b-mercaptoethanol, penicillin (100 IU/ml) and streptomycin (100 mg/ml). One third of the medium was changed every 3 to 4 days.
Virus Production
Lentiviral constructs were packaged into virus via lipid-mediated transient transfection of the expression constructs and packaging plasmids (pMD2.G and psPAX2) to 293 cells. Lentivirus was purified and concentrated using Lenti-X Maxi Purification kit and LentiX Concentrator (Clontech) according to the manufacturer's protocol. Lentivirus titer was determined using QuickTiter Lentivirus titer kit (Lentivirus-Associated HIV p24; Cell Biolabs) according to the manufacturer's protocol.
Mass Spectrometry to Identify Biotinylated Proteins in HEK Cells
Sample Preparation
Proteins were separated by 4%-12% Nupage gels and visualized by SimplyBlue SafeStain (Life Technologies). Protein bands were excised from each lane encompassing the entire molecular weight range. The resulting bands were divided into $2 mm squares and washed overnight in 50% methanol/ water. These were washed once more with 47.5/47.5/5% methanol/water/acetic acid for 2 hr, dehydrated with acetonitrile and dried in a speed-vac. Reduction and alkylation of disulfide bonds was then carried out by the addition of 30 mL 10 mM dithiothreitol (DTT) in 100 mM ammonium bicarbonate for 30 min to reduce disulfide bonds. The resulting free cysteine residues were subjected to an alkylation reaction by removal of the DTT solution and the addition of 100 mM iodoacetamide in 100 mM ammonium bicarbonate for 30 min to form carbamidomethyl cysteine. These were then washed with aliquots of acetonitrile, 100 mM ammonium bicarbonate and acetonitrile and dried in a speed-vac. The bands were enzymaticly digested by the addition of 300 ng of trypsin in 50 mM ammonium bicarbonate to the dried gel pieces ratio of mg trypsin for 10 min on ice. Depending on the volume of acrylamide, excess ammonium bicarbonate was removed or enough was added rehydrate the gel pieces. These were allowed to digest overnight at 37 C. The resulting peptides were extracted by the addition of 50 mL (or more if needed to produce supernatant) of 50 mM ammonium bicarbonate with gentle shaking for 10 min. The supernatant from this was collected in a 0.5 mL conical autosampler vial. Two subsequent additions of 47.5/47/5/5 acetonitrile/water/formic acid with gentle shaking for 10 min were performed with the supernatant added to the 0.5 mL autosampler vial. Organic solvent was removed and the volumes were reduced by to 15 mL using a speed vac for subsequent analyses. Chromatographic Separations Digestion extracts were analyzed by reversed phase high performance liquid chromatography (HPLC) using a Waters NanoAcquity HPLC and autosampler and a ThermoFisher LTQ linear ion trap mass spectrometer using a nano flow configuration. A 20 mm x 180 mm column packed with 5 mm Symmetry C18 material (Waters) using a flow rate of 15 mL per minute for two minutes was used to trap and wash peptides. These were then eluted onto the analytical column which was a self-packed with 3 micron Jupiter C18 material (Phenomenex) in a fritted 10 cm x 75 mm fused silica tubing pulled to a 5 micron tip. The gradient was isocratic 1% A Buffer for 1 min 250 nL min -1 with increasing B buffer concentrations to 15% B at 15 min, 27% B at 27 min and 40% B at 24.5 min. The column was washed with high percent B and re-equilibrated between analytical runs for a total cycle time of approximately 50 min. Buffer A consisted of 1% formic acid in water and buffer B consisted of 1% formic acid in acetonitrile. (Alternatively, a linear gradient of 1% to 40% B from time 1 min to time 24.5 min is used as an alternative for very low level samples where staining indicates a single band.)
Mass Spectrometry and Analysis
The mass spectrometer was operated in a dependent data acquisition mode where the five most abundant peptides detected in full scan mode were subjected to daughter ion fragmentation. A running list of parent ions was tabulated to increase the number of peptides analyzed throughout the chromatographic run. Peptides were identified from the MS data using SEQUEST algorithms that searched a species-specific database generated from NCBI's non-redundant (nr.fasta) database. Sequest filters used for indication of a positive peptide identification were: XCorr versus Charge State = 1.5, 2.00, 2.50; Sp -Preliminary Score = 500. Two peptides were required for a protein to be considered a positive identification. Data interpretation from all bands was aided by the Scaffold (Proteome Software).
iTRAQ Mass Spectrometry for Rat Primary Cortical Neurons On-Bead Digestion Two biological replicates of proteins enriched with magnetic streptavidin beads were washed 2x with 200 ul of 50mM Tris-HCl buffer (pH 7.5), transferred into new 1.5 mL Eppendorf tubes, and washed 2 more times with 2 M urea/50 mM Tris (pH 7.5) buffer. Following was collected and protein concentrations determined using BCA assay. $400 mg of lysate was incubated with 50 mL anti-GFP antibody crosslinked beads for 4 hr at 4 C. Beads were washed 4 times with nondenaturing lysis buffer and denatured by boiling for 5 min in 2X LDS buffer. Supernatant was run in SDS-PAGE for western blot analysis.
Membrane Yeast Two Hybrid
This assay was used for testing protein interactions involving membrane-associated proteins and soluble cytosolic proteins. The genotype of the host yeast strain NMY51 (Dualsystems Biotech AG, Schlieren, Switzerland) is MATa his3delta200 112 ade2 LYS2::(lexAop) 8-ADE2 GAL4. The bait vector pGBT3-STE harboring TF-Cub-Bait and the prey vector pGPR3-N harboring Nub-Prey were both transformed into the strain NMY51, while the control constructs of either NubiOst1 or NubG-Ost1 was transformed together with the bait vector to serve as a positive or negative control, respectively. Successful co-transformation of both bait and prey plasmids were verified by yeast cell growth on the synthetic complete (SC) medium depleted of Leu and Trp (SC-Leu-Trp). Protein interactions were then identified by challenging yeast cells on the SC medium depleted of Leu, Trp and His, but supplemented with 10 mM of 3-amino-1,2,4-triazole (3AT), to test for HIS3 reporter expression. In the positive control, the growth in the presence of both Cub-bait and Nub-prey indicates both proteins are expressed and correctly inserted into the membrane. In the negative control, a lack of growth in the presence of the non-interacting pair bait-Ost1 indicates that the bait protein is not an auto-activator. Prior to experimentation, to minimize inherent leaky HIS3 expression, co-transformants of bait with Nub-Ost1 were streaked out on SC-Leu-Trp-His medium containing increasing amounts of 3-AT. The amount of 3-AT was determined that can abolish growth in the negative control (bait-NubG-Ost1), but support growth in the positive control (bait-Nubi-Ost1).
Immunostaining
Immunofluorescent labeling of human cells followed standard protocols. Briefly, cells were fixed in 4% paraformaldehyde (Electron Microscopy Sciences), blocked in 10% normal donkey serum (Jackson ImmunoResearch) for 1 hr. Primary antibody was applied overnight at 4 C. Appropriate conjugated AlexaFluor (Molecular Probes, Life Technologies) secondary antibodies were used (488, 594, 647). Hoechst 33342 (Life Technologies) was used as a nuclear stain for some studies. Imaging of cells on plastic surfaces was with an inverted epifluorescence microscope (Eclipse Ti, Nikon Instruments). These images were visualized and processed with the NIS-Elements AR software package (Nikon).
Yeast Spotting Assays
Yeast were cultured in synthetic media consisting of 0.67% yeast nitrogen base without amino acids (Fischer Scientific) supplemented with amino acids (MP Biomedicals) and 2% sugar. Cells were first grown to mid-log phase in synthetic media containing glucose and then re-cultured overnight in synthetic media containing 2% raffinose. Mid-log phase cells were then diluted in synthetic media containing galactose. Typically, cells were induced for six hours at 30 C.Each strain was diluted to a starting OD 600 = 1.0 and serially diluted 5-fold and then spotted on agar plates containing galactose (inducing) or glucose (control) plates.
QUANTIFICATION AND STATISTICAL ANALYSIS
The Quantification of the Membrane-2 Hybrid In the membrane yeast two-hybrid assay, yeast growth phenotypes were scored as 1$4, based on the size of the growth spot, with 4 being the largest size. In the lenient interaction call, protein interactions were considered positive if both repeats got a score of 1 or more; in the stringent call, protein interactions were considered positive, if both scores were higher than 1, or at least one score was 4 and the other no lower than 1. In most analyses, stringent calls were employed for this study.
p Value for Figure 1 and Table 1 Bonferroni Adjusted p values were calculated by DAVID functional annotation clustering website, https://david.ncifcrf.gov.
